Skip to content
Screener

Operating Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.09B
Labcorp Holdings logo
Labcorp HoldingsLH
$451.6M+14.5%
IQVIA logo
IQVIAIQV
$506M0.0%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$14.8M+104%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$39.62M-21.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$2.57M

Segments

By segment

See full
Reportable Segment$146.82M+16.2%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.05B+31.0%
Enterprise value$15.69B+27.0%
P/E32.7×+3.4×
P/S5.8×+0.3×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Depreciation6,5556,77713,30613,471
Amortization155237310473
Total operating expenses560,507476,9761,125,608922,023
Income from operations146,824126,335288,327239,858
Other income (expense), net:
Miscellaneous (expense) income, net(147)(2,875)824(4,691)
Interest income, net4,9861,07810,1037,541
Total other income (expense), net4,839(1,797)10,9272,850

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s operating income?
Medpace Holdings, Inc. (MEDP) reported operating income of $146.82M in Q2 2026.
How has Medpace Holdings, Inc.'s operating income changed year-over-year?
Medpace Holdings, Inc.'s operating income increased by 16.2% year-over-year, from $126.34M to $146.82M.
What is the long-term trend for Medpace Holdings, Inc.'s operating income?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s operating income has grown at a 28.1% compound annual growth rate (CAGR), from $198.62M to $534.94M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Medpace Holdings, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude